"The cardinal rule of sales is to always make it about your...

"The cardinal rule of sales is to always make it about your buyer, which has never been the situation when it comes to imugene".

Ultimately the buyers are the cancer sufferers.
In my opinion it is to early to blame all the share price woes on management. Lets see what the next few years bring. If over the next 2 years the company is taken over for 10's of billions, which isnt to big an assumption of its value from what we are told, led to believe, credit goes to management regardless of the tortuous route. We dont know what management are about, their vision, how they go about realising it. I am prepared to give them the benefit of doubt at this stage.